| Hazard Information | Back Directory | [Uses]
JZP-MA-11 is a positron emission tomography (PET) ligand targeting the endocannabinoid α/β-hydrolase domain 6 (ABHD6) enzyme. JZP-MA-11 selectively inhibits ABHD6 with an IC50 value of 126 nM. JZP-MA-11 can cross the blood-brain barrier (BBB). [18F]JZP-MA-11 has?the?potential?for preclinical evaluation targeting the brain ABHD6 in mice and nonhuman primate (NHP)[1]. | [in vivo]
JZP-MA-11 (1.5 mg/kg; IV; 20 min before tracer injection) results in a decrease in radioactivity uptake in ABHD6-rich organs such as, brain, liver, heart, and kidneys[1].
| Animal Model: | C57BL6 mice (female, 10-12-week-old)[1] | | Dosage: | 1.5 mg/kg | | Administration: | IV; 20 min before tracer injection | | Result: | Resulted in a decrease in radioactivity uptake in ABHD6-rich organs such as, brain, liver, heart, and kidneys. |
| [References]
[1] Karine Mardon, et al.Utilizing PET and MALDI Imaging for Discovery of a Targeted Probe for Brain Endocannabinoid?α/?β-Hydrolase Domain 6 (ABHD6). J Med Chem. 2022 Dec 14. DOI:10.1021/acs.jmedchem.2c01485 |
|
| Company Name: |
TargetMol
|
| Tel: |
400-821-0310 15002144251 |
| Website: |
www.targetmol.cn/ |
|